Barclays Maintains Overweight on Adient, Raises Price Target to $54
Portfolio Pulse from Benzinga Newsdesk
Barclays analyst Dan Levy maintains an Overweight rating on Adient (NYSE:ADNT) and raises the price target from $50 to $54.
August 04, 2023 | 1:09 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Barclays maintains an Overweight rating on Adient and raises the price target from $50 to $54, which could lead to a positive market reaction.
The raised price target by Barclays indicates a positive outlook for Adient. This could lead to increased investor confidence and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100